HomeCGEM • NASDAQ
add
Cullinan Therapeutics Inc
Previous close
$7.24
Day range
$7.02 - $7.63
Year range
$6.85 - $24.99
Market cap
442.61M USD
Avg Volume
517.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 55.00M | 27.93% |
Net income | -48.50M | -30.56% |
Net profit margin | — | — |
Earnings per share | -0.74 | 13.95% |
EBITDA | -54.92M | -27.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 303.83M | -29.83% |
Total assets | 579.68M | 28.98% |
Total liabilities | 27.84M | 17.16% |
Total equity | 551.84M | — |
Shares outstanding | 59.01M | — |
Price to book | 0.77 | — |
Return on assets | -22.89% | — |
Return on capital | -23.99% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -48.50M | -30.56% |
Cash from operations | -43.16M | -12.83% |
Cash from investing | 36.80M | 184.08% |
Cash from financing | — | — |
Net change in cash | -6.35M | 73.77% |
Free cash flow | -26.52M | -9.35% |
About
Founded
2016
Website
Employees
111
